Search for content, post, videos

Ultimovacs receives Intention to Grant Notice on European Patent

Carlos de Sousa
Ultimovacs has received a Notice of Intention to Grant from the European Patent Office (EPO) concerning its European Patent application on the use of vaccine-checkpoint inhibitor combinations to treat cancer. Subject to grant formalities including translations and fee disbursement, the European p
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.